chr11-2270096-G-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_005170.3(ASCL2):c.237C>A(p.His79Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000558 in 1,504,578 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H79Y) has been classified as Likely benign.
Frequency
Consequence
NM_005170.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ASCL2 | NM_005170.3 | c.237C>A | p.His79Gln | missense_variant | 1/2 | ENST00000331289.5 | NP_005161.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ASCL2 | ENST00000331289.5 | c.237C>A | p.His79Gln | missense_variant | 1/2 | 1 | NM_005170.3 | ENSP00000332293.4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 151882Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000568 AC: 6AN: 105584Hom.: 0 AF XY: 0.0000836 AC XY: 5AN XY: 59842
GnomAD4 exome AF: 0.0000584 AC: 79AN: 1352696Hom.: 0 Cov.: 34 AF XY: 0.0000659 AC XY: 44AN XY: 668042
GnomAD4 genome AF: 0.0000329 AC: 5AN: 151882Hom.: 0 Cov.: 34 AF XY: 0.0000404 AC XY: 3AN XY: 74198
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 21, 2022 | The c.237C>A (p.H79Q) alteration is located in exon 1 (coding exon 1) of the ASCL2 gene. This alteration results from a C to A substitution at nucleotide position 237, causing the histidine (H) at amino acid position 79 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at